AstraZeneca has revealed the ... located in the heart of the city on the Cambridge Biomedical Campus (CBC), is also intended to be a hub for external collaborations and partnerships – now ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... could one day become a biotech hub to rival Boston and San Francisco in ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company said it ...